Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 6 (June)

1. Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study.
   Br J Psychiatry, 186: 500-6. [Abstract] [Full-text]
2. Genome-wide prediction of imprinted murine genes.
   Genome Res, 15(6): 875-84. [Abstract] [Full-text]
3. A brief screening tool for a prepubertal and early adolescent bipolar disorder phenotype.
   Am J Psychiatry, 162(6): 1214-6. [Abstract] [Full-text]
4. Increased amygdala activation during mania: a functional magnetic resonance imaging study.
   Am J Psychiatry, 162(6): 1211-3. [Abstract] [Full-text]
5. The X-box binding protein 1 (XBP1) gene is not associated with methamphetamine dependence.
   Neurosci Lett, 383(1): 194-8. [Abstract] [Full-text]
6. Gene-gene interaction between MAOA and COMT in suicidal behavior.
   Neurosci Lett, 383(1): 151-4. [Abstract] [Full-text]
7. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases.
   Eur Psychiatry, 20(3): 236-42. [Abstract] [Full-text]
8. Clinical impact of late diagnose of bipolar disorder.
   J Affect Disord, 86(2): 313-6. [Abstract] [Full-text]
9. Can the MiniSCID improve the detection of bipolarity in private practice?
   J Affect Disord, 86(2): 289-93. [Abstract] [Full-text]
10. Agitated dysphoria after late-onset loss of response to antidepressants: a case report.
    J Affect Disord, 86(2): 277-80. [Abstract] [Full-text]
11. Factors associated with parent-reported suicide threats by children and adolescents with community-diagnosed bipolar disorder.
    J Affect Disord, 86(2): 267-75. [Abstract] [Full-text]
12. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    J Affect Disord, 86(2): 183-93. [Abstract] [Full-text]
13. Parental death and bipolar disorder: a robust association was found in early maternal suicide.
    J Affect Disord, 86(2): 151-9. [Abstract] [Full-text]
14. Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?
    J Affect Disord, 86(2): 107-27. [Abstract] [Full-text]
15. Prepubertal bipolar disorder: available pharmacological treatment options.
    Expert Opin Pharmacother, 6(4): 547-60. [Abstract] [Full-text]
16. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder.
    Arch Gen Psychiatry, 62(6): 642-8. [Abstract] [Full-text]
17. Depression and mania in patients with epilepsy.
    Epilepsia, 46: 45-9. [Abstract] [Full-text]
18. Neurochemical underpinnings in bipolar disorder and epilepsy.
    Epilepsia, 46: 26-30. [Abstract] [Full-text]
19. The Maudsley Bipolar Disorder Project.
    Epilepsia, 46: 19-25. [Abstract] [Full-text]
20. Neuroimaging of bipolar disorder: emphasis on novel MRI techniques.
    Epilepsia, 46: 14-8. [Abstract] [Full-text]
21. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine.
    Hum Psychopharmacol, 20(4): 225-36. [Abstract] [Full-text]
22. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial.
    Aust N Z J Psychiatry, 39(6): 479-86. [Abstract] [Full-text]
23. Relationship between bipolar illness and binge-eating disorders.
    Psychiatry Res, 135(2): 165-70. [Abstract] [Full-text]
24. Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems.
    Neurosurg Rev, 28(3): 179-86; discussion 187. [Abstract] [Full-text]
25. The psychopharmacology of impulsive behaviour in rats VIII: effects of amphetamine, methylphenidate, and other drugs on responding maintained by a fixed consecutive number avoidance schedule.
    Psychopharmacology (Berl), 180(2): 294-305. [Abstract] [Full-text]
26. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Biol Psychiatry, 57(11): 1467-73. [Abstract] [Full-text]
27. Bipolar depression: a new role for atypical antipsychotics?
    Bipolar Disord, 7: 34-40. [Abstract] [Full-text]
28. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Bipolar Disord, 7: 21-33. [Abstract] [Full-text]
29. Translating knowledge of genetics and pharmacology into improving everyday practice.
    Bipolar Disord, 7: 13-20. [Abstract] [Full-text]
30. The mood spectrum: improving the diagnosis of bipolar disorder.
    Bipolar Disord, 7: 4-12. [Abstract] [Full-text]
31. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Bipolar Disord, 7: 5-69. [Abstract] [Full-text]
32. Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality.
    Acta Psychiatr Scand, 112(1): 72-4. [Abstract] [Full-text]
33. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid.
    Neuropsychopharmacology, 30(6): 1064-75. [Abstract] [Full-text]
34. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Neurosci Lett, 383(3): 272-7. [Abstract] [Full-text]
35. Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism.
    Psychopharmacology (Berl), 180(3): 523-9. [Abstract] [Full-text]
36. Clinical expression of obsessive-compulsive disorder in women with bipolar disorder.
    Rev Bras Psiquiatr, 27(2): 139-42. [Abstract] [Full-text]
37. Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children.
    Pediatr Diabetes, 6(2): 84-9. [Abstract] [Full-text]
38. Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers.
    Neuropsychopharmacology, 30(7): 1400-4. [Abstract] [Full-text]
39. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Neuropsychopharmacology, 30(7): 1223-37. [Abstract] [Full-text]
40. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.
    J Affect Disord, 87(1): 115-9. [Abstract] [Full-text]
41. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression.
    J Affect Disord, 87(1): 17-23. [Abstract] [Full-text]
42. Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys.
    Clin Pract Epidemol Ment Health, 1(1): 4. [Abstract] [Full-text]
43. Gender, suicidality and bipolar mixed states in adolescents.
    J Affect Disord, 87(1): 11-6. [Abstract] [Full-text]
44. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    J Affect Disord, 87(1): 121-30. [Abstract] [Full-text]
45. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states.
    J Affect Disord, 87(1): 101-5. [Abstract] [Full-text]
46. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Curr Med Res Opin, 21(6): 923-34. [Abstract] [Full-text]
47. Review of the efficacy and safety of antidepressants in youth depression.
    J Child Psychol Psychiatry, 46(7): 735-54. [Abstract] [Full-text]
48. Thrombotic thrombocytopenic purpura associated with quetiapine.
    Ann Pharmacother, 39(7): 1346-8. [Abstract] [Full-text]
49. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population.
    Mol Psychiatry, 10(7): 657-68, 616. [Abstract] [Full-text]
50. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
    J Psychopharmacol, 19(4): 422-5. [Abstract] [Full-text]
51. Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study.
    J Psychopharmacol, 19(4): 392-4. [Abstract] [Full-text]
52. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo.
    FASEB J, 19(9): 1166-8. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.